Back to today’s briefing

Story perspectives

K.C. Pharmaceuticals Recalls 3 Million Eye Drops Amid Health Concerns

4/4/2026

37 8 Full Breakdown

Summary

Story summary

K.C. Pharmaceuticals, Inc. has recalled more than 3 million bottles of eye drops.
The U.S. FDA classifies the recall as Class II, indicating possible temporary health issues.
The recall covers brands sold at CVS, Walgreens, and Kroger, including Artificial Tears and Dry Eye Relief.
Consumers should check specific lot codes and stop using the affected products.
CVS is cooperating with the recall and offers refunds for returned products.

1 of 1

Story summary

K.C. Pharmaceuticals, Inc. has recalled more than 3 million bottles of eye drops.
The U.S. FDA classifies the recall as Class II, indicating possible temporary health issues.
The recall covers brands sold at CVS, Walgreens, and Kroger, including Artificial Tears and Dry Eye Relief.
Consumers should check specific lot codes and stop using the affected products.
CVS is cooperating with the recall and offers refunds for returned products.